Diabetes is associated with postural and cognitive domains in Parkinson's disease. Results from a single-center study

Parkinsonism and Related Disorders

Volumn 20, Issue 6, 2014, Pages 671-672

  Giuntini, Martina ^a   Baldacci, Filippo ^a   Del Prete, Eleonora ^a   Bonuccelli, Ubaldo ^a   Ceravolo, Roberto ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Cognitive impairment; Diabetes mellitus; Motor phenotype; Parkinson's disease

Indexed keywords

INSULIN; METFORMIN; SULFONYLUREA DERIVATIVE;

AGED; AGILITY; BODY POSTURE; BRADYKINESIA; CLINICAL FEATURE; COGNITION; COHORT ANALYSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; FEMALE; GAIT DISORDER; HUMAN; LETTER; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MOTOR DYSFUNCTION; PARKINSON DISEASE; PRIORITY JOURNAL; RIGIDITY; SCORING SYSTEM; TREMOR; BODY EQUILIBRIUM; COGNITION DISORDERS; COMPLICATION; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; NONPARAMETRIC TEST; PHYSIOLOGY; SENSATION DISORDERS; SEVERITY OF ILLNESS INDEX;

AGED; COGNITION DISORDERS; COHORT STUDIES; DIABETES COMPLICATIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; POSTURAL BALANCE; SENSATION DISORDERS; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC;

EID: 84900008690     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2014.02.016     Document Type: Letter

References (5)

1. Cereda E., Barichella M., Cassani E., Caccialanza R., Pezzoli G. Clinical features of Parkinson's disease when diabetes came first: a case-control study. Neurology 2012 May 8, 78(19):1507-1511.
2. Kotagal V., Albin R.L., Müller M.L., Koeppe R.A., Frey K.A., Bohnen N.I. Diabetes is associated with postural instability and gait difficulty in Parkinson disease. Parkinsonism Relat Disord 2013 May, 19(5):522-526.
3. Alves G., Larsen J.P., Emre M., Wentzel-Larsen T., Aarsland D. Changes in motor subtype and risk for incident dementia in Parkinson's disease. Mov Disord 2006, 21:1123-1130.
4. Aviles-Olmos I., Limousin P., Lees A., Foltynie T. Parkinson's disease, insulin resistance and novel agents of neuroprotection. Brain 2013 Feb, 136(Pt 2):374-384.
5. Aviles-Olmos I., Dickson J., Kefalopoulou Z., Djamshidian A., Soderlund T., Whitton P., et al. Exenatide and the treatment of patients with Parkinson's disease. J Clin Invest 2013 Jun 3, 123(6):2730-2736.